9258 Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
9258 Wealth Management's BIIB Position: Q1 2020 in Review
9258 Wealth Management sold out of Biogen (BIIB) in Q1 2020, closing a stake of 722 shares — an estimated $214K sold.
9258 Wealth Management first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $235K in Q4 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.
- 9258 Wealth Management reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
- 9258 Wealth Management sold 722 Biogen shares in Q1 2020, an estimated $214K.
- 9258 Wealth Management first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
- 9258 Wealth Management's Biogen position peaked at $235K in Q4 2018.
- 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.
Based on 9258 Wealth Management's 13F filing for Q1 2020, filed 5 May 2020.